1. Home
  2. BOLD vs FLUX Comparison

BOLD vs FLUX Comparison

Compare BOLD & FLUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • FLUX
  • Stock Information
  • Founded
  • BOLD 2018
  • FLUX N/A
  • Country
  • BOLD United States
  • FLUX United States
  • Employees
  • BOLD 64
  • FLUX N/A
  • Industry
  • BOLD
  • FLUX Industrial Machinery/Components
  • Sector
  • BOLD
  • FLUX Miscellaneous
  • Exchange
  • BOLD Nasdaq
  • FLUX Nasdaq
  • Market Cap
  • BOLD 24.4M
  • FLUX 25.4M
  • IPO Year
  • BOLD 2024
  • FLUX N/A
  • Fundamental
  • Price
  • BOLD $1.17
  • FLUX $1.90
  • Analyst Decision
  • BOLD Buy
  • FLUX Strong Buy
  • Analyst Count
  • BOLD 3
  • FLUX 2
  • Target Price
  • BOLD $4.00
  • FLUX $6.00
  • AVG Volume (30 Days)
  • BOLD 283.9K
  • FLUX 132.4K
  • Earning Date
  • BOLD 08-11-2025
  • FLUX 08-15-2025
  • Dividend Yield
  • BOLD N/A
  • FLUX N/A
  • EPS Growth
  • BOLD N/A
  • FLUX N/A
  • EPS
  • BOLD N/A
  • FLUX N/A
  • Revenue
  • BOLD N/A
  • FLUX $63,074,000.00
  • Revenue This Year
  • BOLD N/A
  • FLUX $11.10
  • Revenue Next Year
  • BOLD N/A
  • FLUX $12.66
  • P/E Ratio
  • BOLD N/A
  • FLUX N/A
  • Revenue Growth
  • BOLD N/A
  • FLUX N/A
  • 52 Week Low
  • BOLD $1.00
  • FLUX $1.15
  • 52 Week High
  • BOLD $4.72
  • FLUX $4.75
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • FLUX 58.26
  • Support Level
  • BOLD N/A
  • FLUX $1.36
  • Resistance Level
  • BOLD N/A
  • FLUX $2.53
  • Average True Range (ATR)
  • BOLD 0.00
  • FLUX 0.20
  • MACD
  • BOLD 0.00
  • FLUX 0.06
  • Stochastic Oscillator
  • BOLD 0.00
  • FLUX 52.14

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About FLUX Flux Power Holdings Inc.

Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.

Share on Social Networks: